Tower Research Capital LLC (Trc) Enveric Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$8.8 - $16.2 $182,784 - $336,490	20,771 Added 102.25%	41,085 $9,000
Q1 2022 May 12, 2022	BUY	$12.5 - $52.0 $253,925 - $1.06 Million	20,314 New	20,314 $7,000
Q4 2021 Feb 14, 2022	SELL	$46.5 - $104.0 $166,051 - $371,384	-3,571 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$80.5 - $175.0 $125,821 - $273,525	-1,563 Reduced 30.44%	3,571 $7,000
Q2 2021 Aug 16, 2021	BUY	$95.0 - $156.5 $487,730 - $803,471	5,134 New	5,134 $12,000

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $686K
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.